LOC729082 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.511800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.747000E-01
Normal-vs-Stage2
6.409200E-01
Normal-vs-Stage3
6.615800E-02
Normal-vs-Stage4
7.644600E-01
Stage1-vs-Stage2
9.951200E-01
Stage1-vs-Stage3
1.479770E-01
Stage1-vs-Stage4
4.542600E-01
Stage2-vs-Stage3
1.066040E-01
Stage2-vs-Stage4
3.212600E-01
Stage3-vs-Stage4
7.192000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.276400E-01
Normal-vs-AfricanAmerican
8.899800E-01
Normal-vs-Asian
4.844200E-01
Caucasian-vs-AfricanAmerican
4.621400E-01
Caucasian-vs-Asian
6.594600E-01
AfricanAmerican-vs-Asian
3.922800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.191600E-01
Normal-vs-Female
6.094200E-01
Male-vs-Female
5.296400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.391000E-01
Normal-vs-Age(41-60Yrs)
8.519200E-01
Normal-vs-Age(61-80Yrs)
4.650400E-01
Normal-vs-Age(81-100Yrs)
1.577040E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.351000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.946200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.828800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.156000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.963600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.236400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.069600E-01
Normal-vs-Daily Drinker
3.017800E-01
Normal-vs-Weekly Drinker
3.913600E-01
Normal-vs-Occasional Drinker
7.544000E-01
Normal-vs-Social Drinker
7.290000E-01
Non Drinker-vs-Daily Drinker
6.208200E-01
Non Drinker-vs-Weekly Drinker
8.605600E-01
Non Drinker-vs-Occasional Drinker
4.307200E-01
Non Drinker-vs-Social Drinker
2.386000E-01
Daily Drinker-vs-Weekly Drinker
8.292600E-01
Daily Drinker-vs-Occasional Drinker
2.775800E-01
Daily Drinker-vs-Social Drinker
1.724200E-01
Weekly Drinker-vs-Occasional Drinker
4.504400E-01
Weekly Drinker-vs-Social Drinker
3.082800E-01
Occasional Drinker-vs-Social Drinker
8.987400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.903800E-01
Normal-vs-Grade 2
3.216400E-02
Normal-vs-Grade 3
1.774440E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.124220E-02
Grade 1-vs-Grade 3
4.235700E-03
Grade 1-vs-Grade 4
2.903800E-01
Grade 2-vs-Grade 3
3.244200E-01
Grade 2-vs-Grade 4
3.216400E-02
Grade 3-vs-Grade 4
1.774440E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.537000E-01
Normal-vs-NonDiabetic
4.805600E-01
Diabetic-vs-NonDiabetic
9.769200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.759600E-01
Normal-vs-NoPancreatitis
5.117200E-01
Pancreatitis-vs-NoPancreatitis
2.089400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.635200E-01
Normal-vs-N1
6.512600E-01
N0-vs-N1
3.536200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.182200E-01
Normal-vs-TP53-NonMutant
5.089200E-01
TP53-Mutant-vs-TP53-NonMutant
1.114180E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
